Journal
British journal of anaesthesia
Publication Date
1-1-2021
Volume
126
Issue
1
First Page
245
Last Page
255
Document Type
Open Access Publication
DOI
10.1016/j.bja.2020.07.022
Rights and Permissions
Timic Stamenic T, Feseha S, Manzella FM, Wallace D, Wilkey D, Corrigan T, Fiedler H, Doerr P, Krishnan K, Raol YH, Covey DF, Jevtovic-Todorovic V, Todorovic SM. The T-type calcium channel isoform Cav3.1 is a target for the hypnotic effect of the anaesthetic neurosteroid (3β,5β,17β)-3-hydroxyandrostane-17-carbonitrile. Br J Anaesth. 2021 Jan;126(1):245-255. doi.org/10.1016/j.bja.2020.07.022. © 2020 The Author(s). Published by Elsevier Ltd on behalf of British Journal of Anaesthesia. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Recommended Citation
Timic Stamenic, Tamara; Feseha, Simon; Manzella, Francesca M; Wallace, Damon; Wilkey, Davis; Corrigan, Timothy; Fiedler, Hanna; Doerr, Patricia; Krishnan, Kathiresan; Raol, Yogendra H; Covey, Douglas F; Jevtovic-Todorovic, Vesna; and Todorovic, Slobodan M, "The T-type calcium channel isoform Ca v 3.1 is a target for the hypnotic effect of the anaesthetic neurosteroid (3β,5β,17β)-3-hydroxyandrostane-17-carbonitrile." British journal of anaesthesia. 126, 1. 245 - 255. (2021).
https://digitalcommons.wustl.edu/open_access_pubs/11690
Multimedia component 1.
